Advanced Medical Solutions Grp PLC Trading Update (7430K)
December 18 2018 - 2:00AM
UK Regulatory
TIDMAMS
RNS Number : 7430K
Advanced Medical Solutions Grp PLC
18 December 2018
18 December 2018
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Trading Update
Winsford, UK, 18 December 2018: Advanced Medical Solutions Group
plc (AIM: AMS), the surgical and advanced woundcare specialist
company, today announces an update on trading for the year ending
31 December 2018.
The Group continues to make good progress and the Board expects
results to be in line with current market expectations.
Chris Meredith, Chief Executive Officer of AMS, said: "The Group
continues to deliver good growth supported by innovative product
development and is well positioned for the future."
The Group expects to publish its Preliminary Results for the
year to 31 December 2018 in March 2019.
- End -
For further information, please contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Nicholas
Brown / Olivia Manser
Investec Bank plc (NOMAD) & Broker Tel: +44 (0) 20 7597
5970
Daniel Adams / Gary Clarence / Patrick
Robb
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payers. AMS has a wide range of products
that include tissue adhesives, sutures, haemostats, internal
fixation devices, silver alginates, alginates and foams, which it
markets under its brands LiquiBand(R) , RESORBA(R) , LiquiBand(R)
Fix8(TM) and ActivHeal(R) as well as supplying under white
label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in 77 countries via a network of multinational or regional
partners and distributors, as well as via AMS's own direct sales
forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 650 employees. For
more information please see www.admedsol.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TSTLLFIDFSLDLIT
(END) Dow Jones Newswires
December 18, 2018 02:00 ET (07:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024